IDXX
IDEXX Laboratories Inc
506.50$
-1.4%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.8% | +10.8% | +10.9% | +12.4% | +8.8% | +12.5% | +18.8% | +4.7% | +8.7% | +6.5% | +10.4% | |
| – | +6.3% | +12.4% | +9.0% | +11.5% | +7.2% | +9.1% | +16.8% | +2.8% | +7.9% | +3.2% | +8.3% | |
| – | +9.1% | +9.6% | +12.5% | +13.1% | +10.0% | +15.0% | +20.3% | +6.1% | +9.3% | +8.6% | +11.8% | |
| – | +1.4% | +1.4% | +8.0% | +8.0% | +13.0% | +6.0% | +14.0% | +58.3% | -25.1% | +15.1% | +14.3% | |
| – | +5.0% | +13.4% | +6.7% | +10.9% | +6.7% | +15.1% | +2.9% | +5.4% | +2.9% | +31.7% | -8.5% | |
| – | +4.7% | +7.4% | +9.5% | +9.6% | +8.3% | +7.9% | +9.2% | +15.5% | -1.2% | +14.4% | +3.9% | |
| – | +15.2% | +16.8% | +17.9% | +19.0% | +12.5% | +25.6% | +34.2% | -3.6% | +22.1% | +2.8% | +20.5% | |
| – | +113.4% | -2.9% | +12.6% | +5.1% | -8.8% | +6.2% | -9.7% | +32.1% | -7.3% | -13.2% | +22.6% | |
| – | +10.8% | +17.8% | +18.4% | +20.1% | +14.1% | +26.8% | +36.4% | -4.7% | +23.4% | +4.6% | +19.3% | |
| – | +25.4% | +23.2% | +18.0% | -31.5% | +17.0% | -15.4% | +97.6% | +14.6% | +19.5% | +2.7% | +19.3% | |
| – | +5.6% | +15.6% | +18.5% | +43.3% | +13.4% | +36.0% | +28.0% | -8.8% | +24.4% | +5.1% | +19.3% | |
| – | +16.0% | +15.7% | +15.8% | +15.8% | +11.5% | +23.4% | +31.1% | -2.5% | +8.6% | +16.3% | +15.1% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.